Global market forecast - CAR-T cell therapy in r/r B-ALL

This MarketVIEW product consists of a detailed Executive presentation (~130 slides) and MS-Excel workbook forecasting the commercial potential ($ 000s) of novel CAR-T therapies (per competitor) in both pediatric and adult r/r B-ALL(new cases) across 9 major Western markets to 2030. A patient-based flow methodology has been devised where three possible intervention scenarios for CAR-T introduction are visualized so that the optimum product positioning can be assessed. In addition, an up-to-date review of B-ALL disease background, epidemiology, current and future treatments is presented along with a comprehensive review of the CAR-T landscape. Pricing and cost effectiveness considerations are also discussed. All assumptions are clearly provided.

iOnco Analytics 2017. All Rights Reserved.